To our knowledge, no report had been published on the prevalence and risk factors of micro- and microalbuminuria in patients with Type 2 diabetes in north of Iran at the time of this study. Hence, studies on diabetes related complications are essential to reduce preventable burden of diabetes. Moreover, further rising is expected in this country in the coming years ( 8). Among the developing countries, Iran is a leading country with the highest number of diabetic patients. The prevalence of diabetes is increasing worldwide, particularly in developing countries ( 7). In addition, microalbuminuria is a marker of the increase of cardiovascular disease ( 1).ĭifferent epidemiological studies revealed marked variation in the prevalence of microalbuminuria in Type 2 diabetic patients, ranging from less than 10% in the United Kingdom ( 3), 36.3% in Southern India ( 4), 40.8% in Albania ( 5), and to more than 41% in China ( 6). Microalbuminuria is the first clinical detectable sign of DN and is considered as an independent predictor of diabetic nephropathy ( 2). One of the long- term complications of diabetes mellitus (DM) is diabetic nephropathy (DN), and it is the leading cause of end-stage renal disease worldwide (American Diabetes Association, 2012) ( 1). Therefore, it seems that controlling blood glucose and lowering blood pressure, even in the absence of hypertension-prehypertension, should be considered for patients with microalbuminuria.Īlbuminuria Iran Type 2 Diabetes Risk Factors Diabetic Nephropathy 1. Prevalence of both micro- and macroalbuminuria was high in the patients of this study.

Albuminuria macro vs micro